Vir Biotechnology Stock Probability of Future Stock Price Finishing Under 3.56
| VIR Stock | USD 6.93 0.06 0.87% |
Vir |
Vir Biotechnology Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Vir Biotechnology for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Vir Biotechnology can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Vir Biotechnology had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 74.2 M. Reported Net Loss for the year was (521.96 M) with loss before taxes, overhead, and interest of (404.44 M). | |
| Vir Biotechnology has about 2.2 B in cash with (446.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 77.0% of the company outstanding shares are owned by institutional investors |
Vir Biotechnology Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Vir Stock often depends not only on the future outlook of the current and potential Vir Biotechnology's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Vir Biotechnology's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 136.2 M | |
| Cash And Short Term Investments | 990.4 M |
Vir Biotechnology Technical Analysis
Vir Biotechnology's future price can be derived by breaking down and analyzing its technical indicators over time. Vir Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Vir Biotechnology. In general, you should focus on analyzing Vir Stock price patterns and their correlations with different microeconomic environments and drivers.
Vir Biotechnology Predictive Forecast Models
Vir Biotechnology's time-series forecasting models is one of many Vir Biotechnology's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Vir Biotechnology's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Vir Biotechnology
Checking the ongoing alerts about Vir Biotechnology for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Vir Biotechnology help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Vir Biotechnology had very high historical volatility over the last 90 days | |
| The company reported the last year's revenue of 74.2 M. Reported Net Loss for the year was (521.96 M) with loss before taxes, overhead, and interest of (404.44 M). | |
| Vir Biotechnology has about 2.2 B in cash with (446.35 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 16.55, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Over 77.0% of the company outstanding shares are owned by institutional investors |
Additional Tools for Vir Stock Analysis
When running Vir Biotechnology's price analysis, check to measure Vir Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vir Biotechnology is operating at the current time. Most of Vir Biotechnology's value examination focuses on studying past and present price action to predict the probability of Vir Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vir Biotechnology's price. Additionally, you may evaluate how the addition of Vir Biotechnology to your portfolios can decrease your overall portfolio volatility.